Teva (TEVA) volatility increases after Berkshire Hathaway (BRK.A) disclosed a stake in the company
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $38.98 -0.54%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) February call option implied volatility is at 78, March is at 47; compared to its 52-week range of 24 to 75 after Berkshire Hathaway (BRK.A) disclosed a stake in the company.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva Pharma (TEVA) call put ratio 1.7 calls to 1 put as share price down 0.79%
- Pegasystems (PEGA) call put ratio 1 call to 3.9 puts with a focus on 210 contracts of October 30 puts
- Pinduoduo (PDD) call put ratio 5.4 calls to 1 put into President Donald Trump and Chinese President Xi Jinping's summit
Create E-mail Alert Related Categories
Option EPS Action, Options, Trader TalkRelated Entities
Warren Buffett, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
